Drug and Alcohol Dependence
Volume 91, Issue 2 , Pages 187-194 , 1 December 2007

Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients

  • Nicholas Lintzeris

      Affiliations

    • National Addiction Centre, Institute of Psychiatry, Kings College London, and South London and Maudsley NHS Trust, P.O. Box 48, 4 Windsor Walk, Denmark Hill, London SE5 8AF, United Kingdom
    • National Drug and Alcohol Research Centre, UNSW, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 431 585 515.
  • ,
  • Timothy B. Mitchell

      Affiliations

    • National Addiction Centre, Institute of Psychiatry, Kings College London, and South London and Maudsley NHS Trust, P.O. Box 48, 4 Windsor Walk, Denmark Hill, London SE5 8AF, United Kingdom
  • ,
  • Alyson J. Bond

      Affiliations

    • National Addiction Centre, Institute of Psychiatry, Kings College London, and South London and Maudsley NHS Trust, P.O. Box 48, 4 Windsor Walk, Denmark Hill, London SE5 8AF, United Kingdom
  • ,
  • Liam Nestor

      Affiliations

    • Institute of Neuroscience, Trinity College, University of Dublin, Dublin, Ireland
  • ,
  • John Strang

      Affiliations

    • National Addiction Centre, Institute of Psychiatry, Kings College London, and South London and Maudsley NHS Trust, P.O. Box 48, 4 Windsor Walk, Denmark Hill, London SE5 8AF, United Kingdom

Received 26 May 2006 ,Revised 30 April 2007 ,Accepted 24 May 2007.

References 

  1. Ball JC, Ross A. The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services and Outcomes. New York: Spring-Verlag; 1991;
  2. Bond A, James D, Lader M. Physiological and psychological measures in anxious patients. Psychol. Med. 1974;4:364–373
  3. Considine J. The reliability of clinical indicators of oxygenation: a literature review. Contemp. Nurse. 2005;18:258–267
  4. Darke S. Benzodiazepine use among injecting drug users: problems and implications. Addiction. 1994;89:379–382
  5. Darke S, Topp L, Ross J. The injection of methadone and benzodiazepines among Sydney injecting drug users 1996–2000: 5-year monitoring of trends from the Illicit Drug Reporting System. Drug Alcohol Rev. 2002;21:27–32
  6. Ernst E, Bartu A, Popescu A, Ileutt K, Hansson R, Plumley N. Methadone-related deaths in Western Australia 1993–99. Aust. N.Z. J. Public Health. 2002;26:364–370
  7. Evans S, Critchfield T, Griffiths R. Abuse liability assessment of anxiolytics/hypnotics: rationale and laboratory lore. Br. J. Addict. 1991;86:1625–1632
  8. Farre M, Teran M, Roset P, Mas M. Abuse liability of flunitrazepam among methadone-maintained patients. Psychopharmacology. 1998;140:486–495
  9. Grass H, Behnsen S, Kimont H, Staak M, Kaferstein H. Methadone and its role in drug-related fatalities in Cologne 1989–2000. Forensic Sci. Int. 2003;132:195–200
  10. Handelsman L, Cochrane KJ, Aronson MJ, Ness RA, Rubinstein KJ, Kanof PD. Two new rating scales for opiate withdrawal. Am. J. Drug Alcohol Abuse. 1987;13:293–308
  11. Kandel D, Huang FY, Davies M. Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend. 2001;64:233–241
  12. Kintz P. Deaths involving buprenorphine: a compendium of French cases. Forensic Sci. Int. 2001;121:65–69
  13. Lintzeris N, Clark N, Winstock A, Muhleisen P, Ritter A, Ali R, et al. National Clinical Guidelines and Procedures for the Use of Buprenorphine in the Management of Opiate Dependence. Canberra: National Drug Strategy, Commonwealth Department of Health and Aged Care; 2006;
  14. Lintzeris N, Mitchell TB, Bond A, Nestor L, Strang J. Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients. J. Clin. Psychopharmacol. 2006;26:274–283
  15. Marsden J, Gossop M, Stewart D, Rolfe A, Farrell M. Psychiatric symptoms among clients seeking treatment for drug dependence. Intake data from the National Treatment Outcome Research Study. Br. J. Psychiatry. 2000;176:285–289
  16. Martin W, Sloan J, Sapira J, Jasinski D. Physiologic, subjective and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin. Pharm. Ther. 1971;12:245–258
  17. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst. Rev. 2002;CD002207
  18. Mikolaenko I, Robinson CA, Davis GG. A review of methadone deaths in Jefferson County, Alabama. Am. J. Forensic Med. Pathol. 2002;23:299–304
  19. Nielsen S, Taylor DA, Dunlop A, Lee N, Dietze P. Buprenorphine and benzodiazepine consumption in Victoria. In: The Australasian Professional Society on Alcohol & Other Drugs (APSAD) Conference. 2005;
  20. Oliver P, Keen J. Concomitant drugs of misuse and drug using behaviours associated with fatal opiate-related poisonings in Sheffield, UK, 1997–2000. Addiction. 2003;98:191–197
  21. Pirnay S, Borron S, Giudicelli C, Tourneau J, Baud F, Ricordel I. A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths. Addiction. 2004;99:978–988
  22. Preston K, Griffiths R, Stitzer M, Bigelow G, Liebson I. Diazepam and methadone interactions in methadone maintenance. Clin. Pharmacol. Ther. 1984;36:534–1534
  23. Stenhouse G, Grieve JH. Drug-related deaths in Grampian, Scotland. Scott. Med. J. 2003;48:111–113
  24. Stitzer M, Griffiths R, McLellan A, Grabowski J, Hawthorne J. Diazepam use among methadone maintenance patients: patterns and dosages. Drug Alcohol Depend. 1981;8:189–199
  25. Ward M, Barry J. Opiate-related deaths in Dublin. Ir. J. Med. Sci. 2001;170:35–37
  26. Wechsler D. Manual for the Wechsler Adult Intelligence Scale. New York: Psychological Corporation; 1955;
  27. Wolf B, Lavezzi W, Sullivan L, Flannagan L. Methadone-related deaths in Palm Beach County. J. Forensic Sci. 2004;49:375–378
  28. Zador D, Sunjic S. Deaths in methadone maintenance treatment in New South Wales, Australia 1990–1995. Addiction. 2000;95:77–84

PII: S0376-8716(07)00221-9

doi: 10.1016/j.drugalcdep.2007.05.019

Drug and Alcohol Dependence
Volume 91, Issue 2 , Pages 187-194 , 1 December 2007